S100A9 and neoplasm: Inflammatory mediator S100A9 was secreted as a damage-associated molecular pattern (DAMP) in the tumor microenvironment (TME) of many inflammatory tumors, including gastric cancer, prostate cancer, and liver cancer (14–16).